Skip to main content
Fig. 4 | Lipids in Health and Disease

Fig. 4

From: A specific combined long-chain polyunsaturated fatty acid supplementation reverses fatty acid profile alterations in a mouse model of chronic asthma

Fig. 4

Sc-LCPUFA supplementation could restore asthma-specific altered LCPUFA profiles (Comparison: HDM vs. sc-LCPUFA). Relative amounts of n-3 and n-6 fatty acids LA, DGLA, AA, EPA, DPA and DHA in (a) murine plasma (b) blood cells and (c) lung cells of asthmatic (HDM) and sc-LCPUFA supplemented (sc-LCPUFA) asthmatic mice on day 35. Data is represented by mean ± SEM out of n = 5–10 for each group. Statistical tests were performed by using One-Way ANOVA with Dunnet’s post-hoc analysis against the disease group (HDM) to statistically compare the results of all four treatment groups (PBS, HDM, EPA and sc-LCPUFA) shown in this article. P-Values were considered as statistically significant *P < 0.05, **P < 0.01, ***P < 0.001

Back to article page